PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-9.50%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
-37.36%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
8.09%
Positive growth while VET shows decline. John Neff would investigate competitive advantages.
19.43%
Margin expansion while VET shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-0.99%
G&A reduction while VET shows 1.58% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
130.20%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
47.70%
Operating expenses growth above 1.5x VET's 7.27%. Michael Burry would check for inefficiency.
-5.97%
Total costs reduction while VET shows 1.47% growth. Joel Greenblatt would examine advantage.
-24.10%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-3.73%
D&A reduction while VET shows 30.41% growth. Joel Greenblatt would examine efficiency.
-13.13%
EBITDA decline while VET shows 77.46% growth. Joel Greenblatt would examine position.
-3.96%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-15.22%
Both companies show declining income. Martin Whitman would check industry conditions.
-6.33%
Both companies show margin pressure. Martin Whitman would check industry conditions.
45.45%
Other expenses growth less than half of VET's 383.00%. David Dodd would verify if advantage is sustainable.
-12.87%
Pre-tax income decline while VET shows 109.62% growth. Joel Greenblatt would examine position.
-3.73%
Pre-tax margin decline while VET shows 146.07% growth. Joel Greenblatt would examine position.
-355.68%
Tax expense reduction while VET shows 232.96% growth. Joel Greenblatt would examine advantage.
12.56%
Net income growth below 50% of VET's 45.86%. Michael Burry would check for structural issues.
24.37%
Net margin growth below 50% of VET's 71.22%. Michael Burry would check for structural issues.
14.68%
EPS growth below 50% of VET's 46.67%. Michael Burry would check for structural issues.
14.47%
Diluted EPS growth below 50% of VET's 50.31%. Michael Burry would check for structural issues.
-1.98%
Both companies reducing share counts. Martin Whitman would check patterns.
-1.72%
Both companies reducing diluted shares. Martin Whitman would check patterns.